Ansbert Gadicke, Director: TCR2 Therapeutics TCRR Sell · Filed 23/05/24

Trade details

Type: Insider sale
Amount: $131,919.6
Shares · price: 70,170 sh · $1.88 a share
Held after: 304,001 sh
Stock: TCR2 Therapeutics TCRR
Person: Ansbert GadickeDirector
Trade date: 23/05/22
Filed: 23/05/24
Days to filing: 2 days

Sold 18.8% of holdings

Share of holding sold: 18.8%

TCR2 Therapeutics trades, last 26 weeks

What else happened in TCR2 Therapeutics around then

Filed or reported within 30 days of the trade day · 23/04/22~23/06/21

Ansbert Gadicke's recent trades

Ansbert Gadicke10% Owner
BuyAktis Oncology
Buy
Aktis Oncology
AKTS
$20M
1,112,777 sh
$20M
Filed 01/14
Traded 01/12
Ansbert GadickeOther
Sell10b5-1 planWerewolf Therapeutics
Sell10b5-1 plan
Werewolf Therapeutics
HOWL
$80.7K
83,230 sh
$80.7K
Filed 25/12/04
Traded 25/12/04
Ansbert GadickeOther
Sell10b5-1 planWerewolf Therapeutics
Sell10b5-1 plan
Werewolf Therapeutics
HOWL
$52.8K
59,277 sh
$52.8K
Filed 25/12/04
Traded 25/12/02
Ansbert GadickeOther
Sell10b5-1 planWerewolf Therapeutics
Sell10b5-1 plan
Werewolf Therapeutics
HOWL
$49.8K
57,225 sh
$49.8K
Filed 25/12/04
Traded 25/12/03
Ansbert Gadicke10% Owner
Sell10b5-1 planWerewolf Therapeutics
Sell10b5-1 plan
Werewolf Therapeutics
HOWL
$59.5K
60,733 sh
$59.5K
Filed 25/12/01
Traded 25/11/26